Business Description
Optipharm Co Ltd
ISIN : KR7153710009
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.38 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | -33.37 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.28 | |||||
Beneish M-Score | -3.12 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EBITDA Growth Rate | 25.7 | |||||
3-Year EPS without NRI Growth Rate | -0.2 | |||||
3-Year FCF Growth Rate | -9.8 | |||||
3-Year Book Growth Rate | -9.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 71.27 | |||||
9-Day RSI | 68.39 | |||||
14-Day RSI | 63.25 | |||||
6-1 Month Momentum % | -9.91 | |||||
12-1 Month Momentum % | -23.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.78 | |||||
Quick Ratio | 1.59 | |||||
Cash Ratio | 1.26 | |||||
Days Inventory | 59.76 | |||||
Days Sales Outstanding | 22.72 | |||||
Days Payable | 12.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -2.36 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.54 | |||||
Operating Margin % | -12.15 | |||||
Net Margin % | -13.24 | |||||
FCF Margin % | -16.14 | |||||
ROE % | -8.93 | |||||
ROA % | -5.69 | |||||
ROIC % | -7.28 | |||||
ROC (Joel Greenblatt) % | -8.77 | |||||
ROCE % | -6.15 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.69 | |||||
PB Ratio | 4.15 | |||||
Price-to-Tangible-Book | 4.2 | |||||
EV-to-EBIT | -52.51 | |||||
EV-to-EBITDA | -282.96 | |||||
EV-to-Revenue | 5.45 | |||||
EV-to-FCF | -33.76 | |||||
Price-to-Net-Current-Asset-Value | 18.38 | |||||
Earnings Yield (Greenblatt) % | -1.9 | |||||
FCF Yield % | -2.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Optipharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 17,775.246 | ||
EPS (TTM) (â‚©) | -161 | ||
Beta | 0.51 | ||
Volatility % | 29.42 | ||
14-Day RSI | 63.25 | ||
14-Day ATR (â‚©) | 176.875592 | ||
20-Day SMA (â‚©) | 6763.5 | ||
12-1 Month Momentum % | -23.41 | ||
52-Week Range (â‚©) | 6110 - 9680 | ||
Shares Outstanding (Mil) | 14.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Optipharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Optipharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Optipharm Co Ltd Frequently Asked Questions
What is Optipharm Co Ltd(XKRX:153710)'s stock price today?
When is next earnings date of Optipharm Co Ltd(XKRX:153710)?
Does Optipharm Co Ltd(XKRX:153710) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |